Research from Redeye, Redeye AB

Redeye

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen). 

Expertise in Denmark, Finland, Norway and Sweden.

Research from Redeye

Redeye AB

Specialists in innovative and fast-growing Nordic companies within Life Science and Technology.

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen).

Equity Bottom-Up

<ul><li>Redeye considers Polygiene’s Q3 figures to be mixed, with higher-than-expected revenues and gross margin, while opex also exceeded our forecast, overall colored by the challenging market conditions.</li><li>Most notably, the company sees signs of recovery, confirming our expectations of a recovery in Q4.</li></ul>

Redeye considers Polygiene’s Q3 figures to be mixed, with higher-than-expected revenues and gross margin, while opex also exceeded our forecast, overall colored by the challenging market conditions.Most notably, the company sees signs of recovery, confirming our expectations of a recovery in Q4.

Polygiene Group (Q3 Initial take): Mixed figures, Recovery Expected in Q4